TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
TRVI

Trevi Therapeutics Inc

Healthcare · Biotechnology

15.20$ +1.3% vs. previous close Closing price · As of: Sep 17, 2026

Investor relations

Report Dates

Investor relations overview for Trevi Therapeutics Inc (TRVI): report dates, earnings surprises, earnings call transcripts and the latest headlines. The next report is scheduled for 08/06/2026.

Next report 08/06/2026
Last report 08/06/2026
Earnings surprise by quarter (%)
Q3 23 · 11.1 % 23 Q4 23 · 11.1 % 23 Q1 24 · -22.2 % 24 Q2 24 · -9.1 % 24 Q3 24 · -18.2 % 24 Q4 24 · 6.1 % 24 Q1 25 · 25.0 % 25 Q2 25 · 10.0 % 25 Q3 25 · 20.0 % 25 Q4 25 · 39.1 % 25 Q1 26 · -28.6 % 26 Q2 26 · 0.0 % 26

EPS estimate beaten

Full history 20 of 32 quarters (63%)
Last 16 quarters 11 of 16 quarters (69%)

Earnings Call Transcripts

Search all transcripts →

  • 05/06/2026 Earnings Call Q1 2026 Open →
  • 03/17/2026 Earnings Call Q4 2025 Open →
  • 11/13/2025 Earnings Call Q3 2025 Open →
  • 08/08/2025 Earnings Call Q2 2025 Open →
  • 05/11/2025 Earnings Call Q1 2025 Open →
  • 03/18/2025 Earnings Call Q4 2024 Open →
  • 11/06/2024 Earnings Call Q3 2024 Open →
  • 08/11/2024 Earnings Call Q2 2024 Open →
  • 05/07/2024 Earnings Call Q1 2024 Open →

News on This Stock

  • 08/06/2026 Trevi Therapeutics, Inc. (TRVI): Results of Operations and Financial Condition; Financial Statements and Exhibits · sec.gov Open ↗

Automatically matched wire and portal stories; external links open the original source.

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Transcripts: transcript archive

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?